发明授权
- 专利标题: Controlled absorption diltiazem formulation
- 专利标题(中): 受控吸收地尔硫卓制剂
-
申请号: US121224申请日: 1987-11-16
-
公开(公告)号: US4917899A公开(公告)日: 1990-04-17
- 发明人: Edward J. Geoghegan , Seamus Mulligan , Donald E. Panoz
- 申请人: Edward J. Geoghegan , Seamus Mulligan , Donald E. Panoz
- 申请人地址: IEX Athlone
- 专利权人: Elan Corporation plc
- 当前专利权人: Elan Corporation plc
- 当前专利权人地址: IEX Athlone
- 优先权: IEX2789/87 19871016
- 主分类号: A61K9/50
- IPC分类号: A61K9/50 ; A61K31/55 ; A61K31/554
摘要:
A diltiazem pellet formulation for oral administration comprises a core of diltiazem or a pharmaceutically acceptable salt thereof in association with an organic acid and a lubricant, and a membrane surrounding the core comprising a multiplicity of sequentially applied and dried layers, each layer containing a major proportion of a pharmaceutically acceptable film-forming, water insoluble, naturally occurring polymer and a minor proportion of a pharmaceutically acceptable film-forming, water soluble polymer. The number of layers in the membrane and the ratio of the water soluble to water insoluble polymer being effective to permit release of the diltiazem from the pellet at a rate allowing controlled absorption thereof over a twelve hour period following oral administration.
公开/授权文献
- US5424042A Apparatus and method for processing wastes 公开/授权日:1995-06-13
信息查询